Actinomycin D for injection
Indication: 1. It has outstanding efficacy in the treatment of Hodgkin's disease (HD) and neuroblastoma, especially in controlling fever. 2. The cure rate of this drug alone for the initial treatment of non-metastatic choriocarcinoma is 90% to 100%, which is similar to the effect of MTX alone. 3. It is also effective for testicular cancer, and is generally used in combination with other drugs. 4. Combining it with radiotherapy to treat childhood Wilms tumor can improve the survival rate, and it is also effective for Ewing sarcoma and rhabdomyosarcoma.
Manufacturer:
Han Hui Pharmaceuticals Company Limited